Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes

• Status: Completed
• Trial end date: 2008-07-01
• Target enrollment: 0
• Participant gender: All

Summary

We want to investigate the effects of pioglitazone on cardiovascular events in Japanese patients with type 2 diabetes.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dokkyo Medical University
• Treatments: Pioglitazone

Criteria

Inclusion Criteria:

• type 2 diabetes HbA1c: more than 7% and less than 9%

Exclusion Criteria:

• insulin treatment